Alginate–Chitosan–PLGA Composite Microspheres Enabling Single-Shot Hepatitis B Vaccination
نویسندگان
چکیده
منابع مشابه
hepatitis b vaccination
one of the most serious kinds of hepatitis is hepatitis b. this condition is more common than aids, and is 100 time more contagious. in iran the most common cause of acute and chronic hepatitis, liver cirrhosis, and also hepatocellar carcinoma in adults, is hepatitis b. more than two billion people are infected and more than 350 million of individuals are carriers of this virus in the entire wo...
متن کاملAnother Shot to Protect People With Diabetes: Add Hepatitis B Vaccination to the Checklist
The average outpatient visit for an adult patient with diabetes involves numerous interventions and discussions:management ofmultiplemedications; assessment of control of glycemia, blood pressure, and dyslipidemia; counseling regarding diet and exercise; screening for diabetes complications; and often assessment and management of other acute and chronic concerns. Now clinicians have another int...
متن کاملImmune Augmentation of Single Contact Hepatitis B Vaccine by Using PLGA Microspheres as an Adjuvant
The present study was aimed to replace the alum type adjuvant for hepatitis B vaccine. The hepatitis B vaccine was encapsulated in poly (DL-lactide-co-glycolide) microspheres by solvent evaporation technique. The formulated microspheres were characterized in terms of morphology, particle size analysis, in vitro release study and in vivo immune response in male Wistar rats. The FT IR spectrum il...
متن کاملThe necessity of booster vaccination after neonatal hepatitis B vaccination
Soon after introducing recombinant hepatitis B virus (HBV) vaccine, universal neonatal vaccination became the corner stone of the preventive measures for this potentially life threatening infection (1-3). By 2006 more than 177 out of 193 member states of world health organization (WHO) introduced HBV vaccination in their national infant immunization programs (1). Following a complete series of ...
متن کاملHepatitis B vaccination in preterm infants
Aim—To investigate the immunogenicity and safety of existing recommendations for hepatitis B vaccination in preterm infants. Methods—Recombinant hepatitis B vaccine (H-B-VAX II, 5 μg per dose) was given to 85 preterm infants divided into two groups, using two diVerent schedules. Forty four group A infants with birthweights of < 2000 g received three doses at 1, 2, and 7 months of age. Forty one...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The AAPS Journal
سال: 2010
ISSN: 1550-7416
DOI: 10.1208/s12248-010-9213-1